Transport mechanisms of trans-1-amino-3-fluoro[1- 14C]cyclobutanecarboxylic acid in prostate cancer cells

Nuclear Medicine and Biology

Volumn 39, Issue 1, 2012, Pages 109-119

  Oka, Shuntaro ^a   Okudaira, Hiroyuki ^a   Yoshida, Yasunori ^a   Schuster, David M ^b   Goodman, Mark M ^b   Shirakami, Yoshifumi ^a  

^a Nihon Medi Physics   (Japan)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amino acid transporters; Anti 14C FACBC; Prostate cancer; System ASC; System L

Indexed keywords

1 AMINO 3 FLUORO 1 CYCLOBUTANECARBOXYLIC ACID C 14; 2 AMINO BICYCLO[2,2,1]HEPTANE 2 CARBOXYLIC ACID; AMINO ACID TRANSPORTER; GLUTAMINE; N ETHYLMALEIMIDE; PHENYLALANINE; RADIOPHARMACEUTICAL AGENT; SERINE; SODIUM ION; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG TRANSPORT; DRUG UPTAKE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PH; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION;

AMINO ACID TRANSPORT SYSTEMS; AMINO ACIDS; BIOLOGICAL TRANSPORT; CARBON RADIOISOTOPES; CARBOXYLIC ACIDS; CYCLOBUTANES; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84855330059     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.06.008     Document Type: Article

References (27)

1. Shoup T.M., Goodman M.M. Synthesis of [F-18]-1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC): a PET tracer for tumor delineation. J Labelled Cpd Radiopharm 1999, 42:215-225.
2. 18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. J Nucl Med 1999, 40:331-338.
3. 18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma. J Nucl Med 2007, 48:56-63.
4. Jani A.B., Fox T.H., Whitaker D., Schuster D.M. Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (anti-[F-18] FACBC) to guide prostate cancer radiotherapy target design. Clin Nucl Med 2009, 34:279-284.
5. 111In-capromab pendetide SPECT/CT. Radiology 2011, 259:852-861.
6. Amzat R., Taleghani P., Savir-Baruch B., Nieh P.T., Master V.A., Halkar R.K., et al. Unusual presentations of metastatic prostate carcinoma as detected by anti-3F-18FACBC PET-CT. Clin Nucl Med 2011, 36:800-802.
7. 18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer. J Nucl Med 2007, 48:46-55.
8. Hediger M.A., Romero M.F., Peng J.B., Rolfs A., Takanaga H., Bruford E.A. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Pflugers Arch 2004, 447:465-468.
9. ™. Advanced Biomedical Knowledges Bioparadigms.org. March 16, 2011. http://www.bioparadigms.org/slc/menu.asp.
10. Meier C., Ristic Z., Klauser S., Verrey F. Activation of system L heterodimeric amino acid exchangers by intracellular substrates. EMBO J 2002, 21:580-589.
11. Fuchs B.C., Bode B.P. Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime?. Semin Cancer Biol 2005, 15:254-266.
12. 18F-fluorocyclobutanecarboxylic acid in human prostate cancer. J Nucl Med 2011, 52:822-829.
13. 18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis. Appl Radiat Isot 2003, 58:657-666.
14. Okamoto Y., Sakata M., Ogura K., Yamamoto T., Yamaguchi M., Tasaka K., et al. Expression and regulation of 4F2hc and hLAT1 in human trophoblasts. Am J Physiol Cell Physiol 2002, 282:C196-204.
15. Bröer S. Amino acid transport across mammalian intestinal and renal epithelia. Physiol Rev 2008, 88:249-286.
16. Devés R., Boyd C.A. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 1998, 78:487-545.
17. Shennan D.B., Thomson J., Barber M.C., Travers M.T. Functional and molecular characteristics of system L in human breast cancer cells. Biochim Biophys Acta 2003, 1611:81-90.
18. Shotwell M.A., Jayme D.W., Kilberg M.S., Oxender D.L. Neutral amino acid transport systems in Chinese hamster ovary cells. J Biol Chem 1981, 256:5422-5427.
19. Mackenzie B., Erickson J.D. Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family. Pflugers Arch 2004, 447:784-795.
20. Li R., Younes M., Frolov A., Wheeler T.M., Scardino P., Ohori M., et al. Expression of neutral amino acid transporter ASCT2 in human prostate. Anticancer Res 2003, 23:3413-3418.
21. Sakata T., Ferdous G., Tsuruta T., Satoh T., Baba S., Muto T., et al. L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Pathol Int 2009, 59:7-18.
22. Boden G., Rezvani I., Owen O.E. Effects of glucagon on plasma amino acids. J Clin Invest 1984, 73:785-793.
23. Sidoryk M., Matyja E., Dybel A., Zielinska M., Bogucki J., Jaskólski D.J., et al. Increased expression of a glutamine transporter SNAT3 is a marker of malignant gliomas. Neuroreport 2004, 15:575-578.
24. Kondoh N., Imazeki N., Arai M., Hada A., Hatsuse K., Matsuo H., et al. Activation of a system A amino acid transporter, ATA1/SLC38A1, in human hepatocellular carcinoma and preneoplastic liver tissues. Int J Oncol 2007, 31:81-87.
25. 11C]alpha-methylaminoisobutyric acid in untreated head and neck cancer studied by PET. Eur J Nucl Med Mol Imaging 2003, 30:72-77.
26. Zhang X., Lin Y., Gillies R.J. Tumor pH and its measurement. J Nucl Med 2010, 51:1167-1170.
27. Borghetti A.F., Piedimonte G., Tramacere M., Severini A., Ghiringhelli P., Guidotti G.G. Cell density and amino acid transport in 3T3, SV3T3, and SV3T3 revertant cells. J Cell Physiol 1980, 105:39-49.